| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2872206 | The Annals of Thoracic Surgery | 2015 | 8 Pages |
Abstract
End-stage heart failure myocardium demonstrated an age-independent increase in CSCs relative to healthy myocardium; however, these CSCs from ESHF patients may have diminished proliferative ability and reduced functionality as an autologous cell therapy candidate. Further investigation is necessary to determine the role of ESHF-derived CSCs within the myocardium.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Brody MD, Sudhish PhD, Rachana PhD, Yin PhD, Evan J. PhD, Zachary N. MD, Srinivasa Raju PhD, Osama T. MD, Keerti MS, Sunjay MD, PhD,